Next Article in Journal
Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
Next Article in Special Issue
Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer
Previous Article in Journal
Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation
Previous Article in Special Issue
Low-Dose-Rate Irradiation Suppresses the Expression of Cell Cycle-Related Genes, Resulting in Modification of Sensitivity to Anti-Cancer Drugs
 
 
Review

Article Versions Notes

Cells 2022, 11(12), 1958; https://doi.org/10.3390/cells11121958
Action Date Notes Link
article pdf uploaded. 17 June 2022 17:02 CEST Version of Record https://www.mdpi.com/2073-4409/11/12/1958/pdf-vor
article xml file uploaded 20 June 2022 11:50 CEST Original file -
article xml uploaded. 20 June 2022 11:51 CEST Update https://www.mdpi.com/2073-4409/11/12/1958/xml
article pdf uploaded. 20 June 2022 11:51 CEST Updated version of record https://www.mdpi.com/2073-4409/11/12/1958/pdf
article html file updated 20 June 2022 11:52 CEST Original file -
article html file updated 21 June 2022 10:09 CEST Update -
article html file updated 12 August 2022 21:04 CEST Update https://www.mdpi.com/2073-4409/11/12/1958/html
Back to TopTop